Table 1.
Demographic data and NET characteristics of study subjects (values are given as mean ± standard deviation and range)
| Demographic data and tumor characteristics | |||
|---|---|---|---|
| Characteristic | n | % | |
| Number of patients | 49 | 100% | |
| Sex | Female | 22 | 44.9% |
| Male | 27 | 55.1% | |
|
Age, years mean ± sd (range) |
61.7 ± 14.1 (18–83) | ||
|
Weight, kg mean ± sd (range) |
76.2 ± 17.1 (48–115) | ||
|
Injected tracer activity, MBq mean ± sd (range) |
145.1 ± 25.2 (100–212) | ||
| Primary | GEP-NET total | 38 | 77.5% |
| Pancreatic | 22 | 57.9% | |
| Gastro-enteric | 16 | 42.1% | |
| Lung | 9 | 18.4% | |
| Other | 2 | 4.1% | |
| NET histological sub-types | G1 | 33 | 67.4% |
| G2 | 6 | 12.2% | |
| G3 | 1 | 2.0% | |
| Atypical carcinoid | 4 | 8.2% | |
| Typical carcinoid | 5 | 10.2% | |
|
KI67, % mean ± sd (range) |
4.2 ± 12.9 (1–90) | ||
| Number of lesions | Primary | 42 | 70.0% |
| Liver metastasis | 8 | 13.3% | |
| Bone metastasis | 0 | 0% | |
| Lymph node metastasis | 9 | 15.0% | |
| Other metastasis | 1 | 1.7% | |